The efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis of randomized controlled trials. [PDF]
Lai Y +7 more
europepmc +1 more source
Observation on the efficacy of TPO receptor agonists and platelet transfusion in chemotherapy-induced thrombocytopenia in malignant tumors. [PDF]
Hu H, Lei D, Liang Y.
europepmc +1 more source
Efficacy and safety of avatrombopag in the treatment of chemotherapy-induced thrombocytopenia in children with acute lymphoblastic leukemia: a single-center retrospective study. [PDF]
Yang H +11 more
europepmc +1 more source
Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies. [PDF]
Li J +8 more
europepmc +1 more source
Effectiveness of partial splenic embolization in colorectal cancer patients with chemotherapy-induced thrombocytopenia: results of a single institution retrospective study. [PDF]
Li D +6 more
europepmc +1 more source
Erratum: A Prediction Model for Chemotherapy-Induced Thrombocytopenia Based on Real-World Data and a Close Relationship Between AST/ALT Ratio and Platelet Count in Patients with Solid Tumors [Corrigendum]. [PDF]
europepmc +1 more source
Chemotherapy-induced thrombocytopenia and platelet transfusion in patients with diffuse large B-cell lymphoma. [PDF]
Lu R, Lin Q, Chen S, Ye X.
europepmc +1 more source
Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter, randomized, double-blind, placebo-controlled, phase II study. [PDF]
Qin S +20 more
europepmc +1 more source
Younger age and previous exposure to radiation therapy are correlated with the severity of chemotherapy-induced thrombocytopenia. [PDF]
Mkhitaryan S +12 more
europepmc +1 more source

